![]()
|
|
||||||||
J. Biol. Chem., Vol. 277, Issue 29, 26479-26485, July 19, 2002
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
§,
¶,From the Medical Research Council Secretory Control Research Group, The Physiological Laboratory, University of Liverpool, Liverpool L69 3BX, United Kingdom
Received for publication, February 25, 2002, and in revised form, May 3, 2002
| |
ABSTRACT |
|---|
|
|
|---|
We have studied the Ca2+ leak
pathways in the endoplasmic reticulum of pancreatic acinar cells by
directly measuring Ca2+ in the endoplasmic reticulum
([Ca2+]ER). Cytosolic
Ca2+ ([Ca2+]C) was
clamped to the resting level by a BAPTA-Ca2+ mixture.
Administration of cholecystokinin within the physiological concentration range caused a graded decrease of
[Ca2+]ER, and the rate of
Ca2+ release generated by 10 pM cholecystokinin
is at least 3× as fast as the basal Ca2+ leak revealed by
inhibition of the endoplasmic reticulum Ca2+-ATPase.
Acetylcholine also evokes a dose-dependent decrease of [Ca2+]ER, with an
EC50 of 0.98 ± 0.06 µM. Inhibition of
receptors for inositol 1,4,5-trisphosphate (IP3) by heparin
or flunarizine blocks the effect of acetylcholine but only partly
blocks the effect of cholecystokinin. 8-NH2 cyclic
ADP-ribose (20 µM) inhibits the action of
cholecystokinin, but not of acetylcholine. The basal Ca2+ leak from the endoplasmic reticulum is not blocked by
antagonists of the IP3 receptor, the ryanodine receptor, or
the receptor for nicotinic acid adenine dinucleotide phosphate.
However, treatment with puromycin (0.1-1 mM) to
remove nascent polypeptides from ribosomes increases Ca2+
leak from the endoplasmic reticulum by a mechanism independent of the
endoplasmic reticulum Ca2+ pumps and of the receptors for
IP3 or ryanodine.
Many physiological and pharmacological responses rely on the
ability of intracellular messengers to generate cytosolic
Ca2+ signals by releasing Ca2+ from the
endoplasmic reticulum (ER)1
(1-4). Thus, in the pancreatic acinar cell the neurotransmitter acetylcholine (ACh) stimulates the release of Ca2+ from the
ER via inositol 1,4,5-trisphosphate (IP3), while the hormone cholecystokinin (CCK) evokes Ca2+ release by a
complex interaction between the messengers IP3, cyclic ADP- ribose, and nicotinic acid adenine dinucleotide phosphate (NAADP) (5). Although it is well established that low concentrations of
these agonists generate long lasting trains of different forms of
cytosolic Ca2+ oscillation (5, 6), there are few data on
the kinetics of Ca2+ in the ER lumen
([Ca2+]ER), particularly during
the action of physiological concentrations of agonists.
After agonist-induced depletion, the Ca2+ content of the ER
is replenished by the sarco/endoplasmic reticulum
Ca2+-ATPase (SERCA) pump, but even in the resting state
there is a basal leak of Ca2+ from the lumen of ER, which
can be revealed by the inhibition of SERCA with thapsigargin or
cyclopiazonic acid (CPA) (7, 8). Although the molecular nature of the
basal leak is still unclear, in permeabilized hepatocytes the
temperature dependence and kinetics of the leak suggest that it occurs
through a channel (9). Missiaen et al. (10) found that in
A7r5 smooth muscle cells the leak rate was fitted by a two-exponential decay.
In skeletal and cardiac muscle, sarcoplasmic reticulum basal
Ca2+ efflux may occur through the ryanodine receptor (11,
12), and in non-muscle cells it has been suggested that basal
Ca2+ leak from the ER reflects the flow of Ca2+
through the IP3 receptor induced by the action of resting
levels of IP3 (13, 14). However in a study in baby hamster
kidney fibroblasts, Hofer et al. (7) clearly demonstrated
that the leak was not blocked by either the IP3 receptor
antagonist heparin or the ryanodine receptor antagonist ruthenium red.
In contrast to the hypothesis that the basal Ca2+ leak
occurs through second messenger-activated Ca2+ channels in
the ER membrane, it has been suggested that the leak could occur
through the translocon pore complex in the ER membrane (8). Recent
studies have suggested that the empty pore of the translocon complex is
permeable to small ions and neutral molecules (15-17). Experimentally,
the permeability of the translocon can be modified by puromycin (16,
17), an adenosine derivative that purges the translocon of nascent
polypeptides, creating an empty pore (18, 19), and we have used this
tool to investigate for the first time the permeability of the
translocon pore to Ca2+.
In this study we have investigated the basal and agonist-evoked
pathways of Ca2+ leak by directly measuring the depletion
of [Ca2+]ER in isolated pancreatic
acinar cells. Moreover, to avoid the profound regulatory effects of
cytosolic Ca2+
([Ca2+]C) on Ca2+
release channels (20), [Ca2+] in the solution bathing the
ER was "clamped" at a quasi-resting level (~90 nM) by
dialyzing the cell with a mixture of calcium and the Ca2+
chelator BAPTA. This provides a particularly sensitive method for
studying very slow Ca2+ fluxes.
Using this experimental approach we have set out to study the
following: (i) the depletion of
[Ca2+]ER by physiological doses of
CCK and ACh, (ii) the relative magnitudes of the basal Ca2+
leak and the Ca2+ leak stimulated by physiological doses of
agonists, (iii) the contribution of IP3 and ryanodine
receptors to agonist-evoked and basal Ca2+ leak, and (iv)
the effect on [Ca2+]ER on the
dissociation of nascent polypeptide chains from the ribosome with puromycin.
Cell Preparation and Solutions--
Mouse pancreatic acinar
cells were isolated by digestion with purified collagenase (200 units
ml Patch Clamping and Dialysis of Single Acinar Cells--
Single
cells were dialyzed with intracellular solution using the whole-cell
patch clamp configuration (21) with microelectrodes of resistance 2-5
M Permeabilization of Acinar Cells--
Cells attached to cover
slips were perfused with intracellular medium containing 0.5 units/ml
reduced streptolysin O (Corgenix UK, Peterborough, UK) for 30 s at
room temperature (7, 22). Experiments were carried out in medium with
an ionic composition identical to the patch-pipette intracellular solution.
Measurement of [Ca2+]ER--
Averaged
measurements of the ratio of fluorescence at 340 nm to fluorescence at
380 nm were made at 5-s intervals. In experiments with low,
physiological doses of CCK, analysis was performed only in the
basolateral, non-nuclear area of the acinar cell, where the density of
ER is highest (23, 24); this area also has a lower density of other
organelles and is less susceptible to movement artifacts.
[Ca2+]ER was estimated from ratio
measurements by an in situ cell calibration (25) using
Rmin values obtained with 10 µM ionomycin (Iono) and 10 mM EGTA, and
Rmax values with 10 µM ionomycin and 20 mM CaCl2. The Kd
for fura-2FF-free acid was found to be 31.5 µM by a
cell-free calibration using Ca2+/EGTA buffers (Molecular
Probes Europe BV).
Chemicals and Statistics--
All chemicals were obtained from
Sigma-Aldrich Co. Ltd. unless otherwise stated. All quantitative data
refer to fluorescence ratios of fura-2FF-loaded cells and are
presented as means ± S.E. of the mean. Statistical comparisons
were by paired or unpaired two-tailed Student's t test, and
analysis of sigmoid curves was performed with Microcal Origin using a
Boltzmann fit.
Following permeabilization of the plasma membrane or whole-cell
dialysis of dye-loaded pancreatic acinar cells, the ratio of
fluorescence at 340 to 380 nm rose as cytosolic dye was washed out (8).
In 51 fura-FF-loaded patch-clamped cells, the mean ratio in the
basolateral non-nuclear area after dialysis was 0.63 ± 0.03, corresponding to a mean apparent
[Ca2+]ER of 80 µM.
Physiological Concentrations of Cholecystokinin Deplete
[Ca2+]ER--
CCK (CCK-8, sulfated form)
generated stepwise decreases in ratio, but at picomolar concentrations
of the agonist the ratio reached the new steady-state level relatively
slowly. At 1 pM CCK, the plasma concentration seen in the
fasting state in the mouse2
and in humans (26), there was a small but detectable decrease in ratio
(Fig. 1). In 7 cells the mean decrease
was 0.014 ± 0.003 (Fig. 2). However
at 10 pM CCK, a concentration seen in the plasma after a
meal, there was a more substantial mean decrease in ratio of 0.043 ± 0.006 (13 cells). The CCK-induced decreases in ratio were uniform
throughout the basolateral non-nuclear area of the cell, where the
resting ratio was highest. 10 nM CCK evoked a large average
decrease in the ratio of 0.142 ± 0.005 (Fig. 2).
Depletion of [Ca2+]ER by Different Doses
of Acetylcholine--
ACh (10 nM to 100 µM)
caused a sharp decrease in ratio (Fig. 3)
with low concentrations (10-100 nM) often being associated with a small "rebound" from the initial decrease (Fig.
3B). The decrease in the ratio evoked by ACh was most
pronounced in the basal area of the cell and was uniform in this
region. In other regions of the cell including the lateral and apical
regions, ratio decreases had similar time courses but slightly smaller amplitudes (Fig. 3B). The EC50 for the
ACh-evoked decrease in ratio was 0.98 ± 0.06 µM
(Fig. 3C). In 10 cells 10 µM ACh gave a mean
decrease in ratio of 0.135 ± 0.024; this was similar in size to
the decrease evoked by 10 nM CCK (Fig. 2). In the presence of a supramaximal concentration of ACh, 10 nM CCK was
unable to cause further depletion of
[Ca2+]ER (n = 5, data not shown).
The Basal Leak Is Considerably Smaller than the Leak Evoked by 10 pM CCK--
After a short lag, the application of the
SERCA pump inhibitor CPA (10 µM) evoked a steady decrease
in the ratio (Fig. 4). This is consistent
with the unmasking of the basal leak of Ca2+ from
intracellular stores following inhibition of Ca2+ uptake.
Thapsigargin (2 µM) evoked a quantitatively similar
depletion of [Ca2+]ER (data not
shown). The mean rate of decrease evoked by CPA in 14 cells was
0.018 ± 0.006 min IP3 Receptor Antagonists Block the Action of ACh but
Only Partially Block the Action of CCK and Do Not Block the Basal
Leak--
In 17 cells dialyzed with the competitive IP3
receptor antagonist heparin (Mr 6000; 500 µg/ml) the mean resting ratio (0.59 ± 0.03) was not
significantly different from cells dialyzed with control pipette
solution. Heparin substantially blocked the response to ACh (Fig.
5A), and in 10 cells dialyzed
with heparin the response to 10 µM ACh was decreased by
80% compared with control cells (Figs. 2 and 5A). Heparin
did not completely block the effect of CCK (Fig. 5A). In
heparin-dialyzed cells the mean response to 10 nM CCK was
not different from the mean response in control cells (Figs. 2 and
5A); however the effect of 10 pM CCK was more than halved by heparin (Fig. 2). In heparin-dialyzed cells CPA was
still able to reveal the basal leak (0.012 ± 0.005 min Ryanodine Receptor Antagonists Substantially Inhibit the Action of
CCK but Not the Effect of ACh or the Basal Leak--
Dialysis with
8-amino-cyclic ADP-ribose (20 µM, Molecular Probes Europe
BV), a competitive inhibitor of cyclic ADP-ribose action (29, 30), had
no effect on mean resting [Ca2+]ER
(mean ratio = 0.67 ± 0.08 in the presence of 8-amino-cyclic ADP-ribose, n = 7) or on the action of ACh, but blocked
the depletion of [Ca2+]ER by 10 pM CCK (Fig. 6A).
In 5 cells dialyzed with this inhibitor the mean ratio decrease evoked
by 10 pM CCK was reduced by 87 ± 11%
(p < 0.02 compared with control cells). In the
presence of 8-amino-cyclic ADP-ribose, CPA was still able to deplete
the Ca2+ store at a rate similar to in control conditions
(0.02 ± 0.009 min Puromycin Evokes a Decrease in
[Ca2+]ER--
In patch-clamped and dialyzed
cells the protein synthesis inhibitor puromycin (100-500
µM) produced an initial decrease in ratio, which slowed
down after a short period (Fig.
7A). Mean fura-2FF ratio
decreases with 100 and 500 µM puromycin were 0.08 ± 0.02 and 0.167 ± 0.04, respectively (10 cells). Ratio
measurements in acinar cells loaded with the low-affinity
Ca2+ indicator mag-fura-2 and dialyzed with
BAPTA/Ca2+ intracellular solution confirmed the ability of
puromycin to deplete [Ca2+]ER
(n = 4; data not shown). We also studied the effects of
puromycin in fura-2FF-loaded acinar cells permeabilized by streptolysin
O, because this allowed faster changes of bathing solution during the
experiment. Responses to puromycin were seen in permeabilized cells
(Fig. 7B), and the mean ratio decrease evoked by 500 µM puromycin was 0.11 ± 0.02 (n = 16), and by 1 mM puromycin 0.14 ± 0.03 (n = 7). At 20 µM, puromycin had no
effect (n = 4). To exclude the possibility that the
effects of puromycin were mediated via agonist-activated
Ca2+ release channels, we applied puromycin to
permeabilized cells during blockade of IP3 and ryanodine
receptors. In the presence of the IP3 receptor inhibitor
heparin (500 µg/ml), puromycin (500 µM) decreased the
mean ratio of 10 permeabilized cells by 0.091 ± 0.015 (Fig.
8A), and in the presence of
the ryanodine receptor antagonist ruthenium red (10 µM)
puromycin decreased the mean ratio of 8 permeabilized cells by
0.074 ± 0.019 (Fig. 8B). Neither of these values was
significantly different from the effect of puromycin alone. To
investigate the possibility that the depletion of
[Ca2+]ER by puromycin could be
because of a decreased activity of the SERCA pump rather than an
increase in Ca2+ permeability of the ER membrane, we
studied the effect of puromycin on
[Ca2+]ER when SERCA was inhibited
by CPA. Puromycin (500 µM) accelerated the
Ca2+ leak evoked by CPA (Fig 8C). In 36 cells
the mean Ca2+ leak was increased from 0.013 ± 0.002 to 0.018 ± 0.002 (p < 0.01, paired Student's
t test).
In this study we were able to dissociate the effects of
physiological doses of agonists on the initial or intrinsic
Ca2+ efflux from the ER from any effects on
Ca2+ signaling due to secondary Ca2+-induced
Ca2+ release. This was achieved by direct measurements of
[Ca2+]ER while
[Ca2+]C was clamped at a
quasi-resting level with a BAPTA/Ca2+ mixture. In these
highly sensitive experimental conditions, where feedback of
Ca2+ on its own efflux was prevented, we were able to
resolve the depletion of [Ca2+]ER
produced by the hormone CCK at 1 pM (the fasting plasma
level), and at 10 pM, a level achieved in the plasma after a meal. 1 and 10 pM CCK produced ratio changes
corresponding to ~10 and 32% of the decrease induced by a
supramaximal dose of CCK, respectively. Our experiments indicate that
SERCA pumps can balance the leak induced by all doses of CCK in the
physiological range and prevent substantial depletion of the store.
This is important because substantial depletion of ER can inhibit
protein synthesis, facilitate protein degradation and affect
protein folding (33-37).
A recent study by Pinton et al. (38) in HeLa cells has
indicated that overexpression of the anti-apoptotic protein bcl-2 can
decrease the Ca2+ content of the ER, suggesting that this
protein could mediate (or regulate) Ca2+ leak from the ER.
Moreover, this study implies a new "trophic" action of low
physiological doses of Ca2+-releasing hormones,
i.e. protection of the ER from Ca2+ overload and
consequently from apoptotic destruction of the cell.
Previous measurements of cytosolic Ca2+ have indicated that
in intact cells physiological concentrations of CCK generate, after a
delay of 1-2 min, a mixture of fast, local spikes and slow global Ca2+ oscillations (5, 30, 39). Our study describes an
increase of the permeability of the ER that is purely due to action of the hormone (without amplification by Ca2+-induced
Ca2+ release). The mechanism by which moderate increases in
Ca2+ efflux from the ER are converted into different forms
of Ca2+ oscillation by other cellular mechanisms is an
interesting subject for further theoretical and experimental studies.
For ACh the physiological concentration range in the vicinity of the
pancreatic acinus is unknown, therefore we have characterized the
effects of a broad range of ACh concentration on
[Ca2+]ER. The ability of low doses
of ACh (10 and 100 nM) to generate a pattern of short
lasting local Ca2+ spikes similar to that produced by
IP3 infusion into patch-clamped cells (6) has been well
characterized (5, 39). Our measurements of
[Ca2+]ER suggest that 10 and 100 nM ACh cause between 13 and 25% of the maximal
agonist-dependent ratio changes, respectively. The
depletion of [Ca2+]ER induced by
these doses of ACh, and by physiological doses of CCK, is clearly
quantitatively similar. Therefore the difference in the patterns of
cytosolic Ca2+ responses of the two agonists cannot simply
be explained by different levels of Ca2+ efflux from the
ER.
In this study we found that the ability of ACh to induce
Ca2+ leak from the ER was blocked by heparin, a competitive
IP3 receptor antagonist (40), and by flunarizine, which
does not affect IP3 binding to its receptor but blocks the
Ca2+ release channel activated by IP3 (27, 28).
This strongly suggests that the primary mechanism of ACh-induced
Ca2+ leak is mediated by IP3 receptors.
In contrast, the role of IP3 receptors in acinar cell
Ca2+ signaling by CCK is more complex. Using a biochemical
radioreceptor assay Matozaki et al. (41) showed that
supraphysiological (>50 pM) concentrations of CCK generate
measurable amounts of IP3, and studies using permeabilized
cells (42) and patch-clamped cells (5, 43) have reported that
inhibitors of the IP3 receptor completely block CCK-evoked
[Ca2+]C signals. However in
another study Thorn et al. (39) described that when acinar
cells were dialyzed with low concentrations (<250 µg/ml) of heparin,
physiological doses of CCK (5-20 pM) still produced long
lasting oscillations in [Ca2+]C
(although short, IP3-type
[Ca2+]C spikes were blocked). In
the present study in which "intrinsic," messenger-evoked
Ca2+ efflux from the ER and secondary
Ca2+-induced Ca2+ release were dissociated, we
found that inhibition of the IP3 receptor caused partial
inhibition of the effect of 10 pM CCK, as did inhibition of
the ryanodine receptor with 8-NH2 cyclic ADP-ribose. These
data support the hypothesis that although ACh-induced efflux is
mediated by IP3, physiological concentrations of CCK stimulate efflux dependent on multiple messengers, including
IP3 and cyclic ADP-ribose. Because inhibition of
IP3 receptors has been found to block
[Ca2+]C oscillations evoked by the
putative Ca2+ releasing messengers cyclic ADP-ribose and
NAADP (5), this suggests that CCK-evoked
[Ca2+]C oscillations rely on the
recruitment of IP3 receptors to amplify the
[Ca2+]C signal. Our data show that
the CCK-induced Ca2+ efflux is partially dependent on
IP3 receptors. We found that heparin did not block the
depletion of [Ca2+]ER by 10 nM CCK, suggesting that although nanomolar concentrations
of CCK do generate IP3 (41), when IP3 action is
blocked by heparin other CCK-stimulated messengers could be able to
evoke a substantial release of Ca2+ from the ER. Our
observations that in the presence of supramaximal doses of ACh, the
addition of supramaximal doses of CCK is unable to deplete
[Ca2+]ER further, suggesting that
although primary CCK-induced Ca2+ efflux does involve
additional Ca2+-releasing messengers, it does not involve a
separate Ca2+ store. Qualitatively similar time courses of
[Ca2+]ER were seen within
different regions of a single cell during depletion of
[Ca2+]ER with secretagogues and
with CPA (Figs. 3 and 4). This supports the concept that the
endoplasmic reticulum of the pancreatic acinar cell acts as a single
agonist-releasable Ca2+ store (8, 22, 24).
Hofer et al. (7) reported that neither heparin nor the
ryanodine receptor antagonist ruthenium red blocked the basal leak revealed by SERCA inhibition. Our study supports this finding. We
showed that cells dialyzed with heparin had a similar resting [Ca2+]ER to control cells,
suggesting no substantial differences from control cells in the
pump/leak relationship. Neither heparin, nor the membrane-permeant
Ca2+ channel blocker flunarizine, which does not affect
IP3 binding to its receptor but has been reported to
inhibit Ca2+ release by IP3 (27, 28), blocked
the basal leak evoked by CPA. Furthermore, neither of the two ryanodine
receptor antagonists used (ruthenium red and 8-NH2 cyclic
ADP-ribose) nor nifedipine or verapamil, which in sea urchin eggs
completely block the Ca2+ release evoked by NAADP (32), had
any effects on the basal Ca2+ leak. We therefore found no
evidence to suggest that in the pancreatic acinar cell the basal
Ca2+ leak occurs through any of the Ca2+
release channels so far identified in the ER membrane.
In contrast it has been hypothesized that the basal Ca2+
leak from the ER into the cytosol may occur through the aqueous pore in
the translocon of the ER membrane during the protein synthetic cycle
(8). During the normal cycle of protein synthesis the permeability of
the translocon is tightly controlled, possibly because of the binding
of the ribosome to the cytosolic surface of the translocon pore (44).
The permeability of the translocon is also regulated at the luminal
side of the pore by the prominent ER chaperone BiP (45), this
protein being released from the translocon shortly after the completion
of ribosome-nascent chain targeting. However in the empty state, when
the translocon pore is ribosome-bound but unoccupied by polypeptide,
the ribosome-translocon complex seems to allow the passage of small
molecules (17).
In the present study we have examined the effect of puromycin on the
Ca2+ permeability of the ER membrane, and found a
substantial puromycin-induced Ca2+ efflux. Puromycin is an
antibiotic that selectively terminates ribosomal translation by
releasing the nascent polypeptide from the protein channel of the
ribosome (18, 19). Simon et al. (15, 16) used an
electrophysiological approach to show that in pancreatic rough
microsomes puromycin activates an ion-permeable pore. Interestingly,
spontaneous openings of large conductance ion channels in the ER
membrane, possibly representing subconductance states of the translocon
channel, were reported even in the absence of puromycin (16). These
spontaneous openings could be responsible for the basal
Ca2+ leak. If such a translocon-mediated Ca2+
leak exists, then it should be particularly prominent in the pancreatic
acinar cell with its extremely well developed rough endoplasmic ER and
very high protein-synthesizing activity. Importantly, a very recent
study by Potter and Nicchitta (46) has demonstrated that ribosomes
maintain stable associations with translocons after the termination of
protein synthesis. According to our results, in the protein-free state
such endogenous ribosome-translocon complexes could serve as mediators
of the basal Ca2+ leak from the ER.
In our study we have shown, for the first time, that removal of the
polypeptide chain from the ribosome by puromycin causes a depletion of
[Ca2+]ER by a mechanism
independent of IP3 receptors and ryanodine receptors and
independent of inhibition of the SERCA pump. Our study therefore
provides experimental support for the hypothesis that the basal
Ca2+ leak from the rough ER occurs through translocon pores
in the ER membrane.
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
1, Worthington Biomedical Corp., Lakewood NJ) as
described previously (8). Freshly isolated cells were incubated with 5 µM fura-2FF/AM (Teflabs, Austin TX) or 5 µM
mag-fura-2/AM (Molecular Probes Europe BV, Leiden, The Netherlands) and
pluronic F-127 (0.025%) for 30-45 min at 37 °C. Cells were
attached to poly(L-lysine)-coated cover slips, installed in
a flow chamber and placed on the stage of a Nikon Diaphot inverted
fluorescence microscope (Nikon Ltd., Kingston, UK). Imaging experiments
were performed at room temperature (20-22 °C). Extracellular
solutions contained (in mM): NaCl, 140; KCl, 4.7;
MgCl2, 1.13; CaCl2, 1; glucose, 10; and
HEPES-NaOH, 10 (pH 7.2) and were perfused rapidly under gravity using
electronic valves (Lee Products Ltd., Gerrard's Cross, Bucks, UK).
Cells were alternatively illuminated by 340 and 380 nm light from a monochromator using a ×40, 1.3 NA objective lens, and emission light
with a wavelength longer than 400 nm was collected. Images from a CCD
camera (Photonic Sciences, Beaconsfield, UK) were digitized, averaged,
and analyzed using a Quanticell 700 m imaging system from Visitech
International (Sunderland, UK). In order to remove fura-2FF or
mag-fura-2 from the cytosol and control the composition of the
intracellular medium, imaging experiments were performed either with
patch-clamped cells after dialysis of the cytosol (21) or with
streptolysin O-treated cells after permeabilization of the plasma
membrane. Experiments with streptolysin O-permeabilized cells allowed
the composition of the solution bathing the ER to be changed rapidly
(7, 22).
made from borosilicate glass capillaries (GC150TF-7.5, Harvard
Apparatus Ltd., Kent, UK) and an EPC-8 amplifier (Heka elektronik,
Lambrecht/Pfalz, Germany). The intracellular solution contained (in
mM): KCl, 120; NaCl, 20; HEPES-KOH, 10; ATP, 2;
MgCl2, 1.13; BAPTA, 10; CaCl2, 2 (pH 7.2), so
that free cytosolic [Ca2+] was clamped at ~90
nM (8).
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

View larger version (34K):
[in a new window]
Fig. 1.
Effects of physiological doses of CCK (1 and
10 pM) on
[Ca2+]ER in a
dialyzed, fura-2FF-loaded acinar cell. A,
montage of brightfield image (a) and fluorescence ratio
images (b-f) obtained during illumination at 340 and 380 nm, with the pseudocolor ratio scale shown on the left.
Images show the fluorescent ratio in the control state (b),
after continuous incubation with 1 pM CCK for 11 min
(c), after incubation with 10 pM CCK for 7 min
(d), following washout of CCK (e), and
in the presence of ionomycin (10 µM) and EGTA (10 mM) (Iono/EGTA) (f). B,
time course of the change in ratio representing a fall in
[Ca2+]ER. CCK concentration is in
picomolar. Ratio measurements were made in the basolateral area
indicated in the brightfield image in a, and
arrows in B indicate the time points at which
corresponding ratio images shown in A (b-f) were
captured.

View larger version (19K):
[in a new window]
Fig. 2.
Mean decreases in ratio (± S.E.) evoked by
CCK and ACh in cells dialyzed with control BAPTA/Ca2+
intracellular solution and in cells dialyzed with intracellular
solution containing heparin. Control data are represented by
open bars, and the data from experiments with heparin (500 µg/ml) are shown by solid bars. *, statistically
significant difference (p < 0.01) compared with
control intracellular solution, which was obtained by unpaired
Student's t test.

View larger version (29K):
[in a new window]
Fig. 3.
Depletion of
[Ca2+]ER by
different doses of ACh in dialyzed cells. A, montage of
brightfield image (a) showing basal (red),
lateral (pink), and apical (orange) regions of
interest and (b-d) fluorescence ratio images obtained
during illumination at 340 and 380 nm, with the pseudocolor ratio scale
shown on the left. Ratio images show the control state
(b), the effect of 1 µM ACh (c),
and the effect of ionomycin (10 µM) and EGTA (10 mM) (Iono/EGTA) (d). B,
time course of ratio changes in basal, lateral, and apical areas
showing the decrease in ratio with increasing concentrations of ACh
(µM) with a small "rebound" effect of 0.1 µM ACh. Arrows indicate the time points at
which corresponding ratio images in A (b-d) were
recorded. C, plot of decrease in mean ratio (data normalized
relative to effect of 10 µM ACh) against log[ACh]
(M), with half-maximal depletion at 0.98 ± 0.06 µM. Numbers in parentheses refer to the number
of cells for each data point.
1, much smaller than the rate of
decrease of the ratio due to 10 µM ACh (0.15 ± 0.02 min
1, n = 8). When 10 pM CCK
was applied to cells in which the basal leak had already been revealed
by CPA treatment the mean rate of Ca2+ loss was accelerated
(Fig. 4). The decreases in the ratio evoked by CPA and CCK were
greatest in the basolateral area; slightly smaller decreases with
similar kinetics were seen throughout the cell (Fig. 4). In 7 cells, 10 pM CCK significantly increased (p < 0.05, paired Student's t test) the mean rate of decline evoked by
CPA (by 265 ± 82%), whereas in 6 cells 1 pM CCK
increased the CPA-evoked rate of decline by only 10 ± 20%.

View larger version (35K):
[in a new window]
Fig. 4.
Relative magnitudes of the basal
Ca2+ leak revealed by CPA and the
Ca2+ leak evoked by a physiological
concentration of CCK in a dialyzed acinar cell. A,
montage of brightfield image (a) showing basolateral
(blue) and apical (red) regions of interest, and
fluorescent ratio images (b-f) with the pseudocolor ratio
scale shown on the left. Ratio images show the control state
(b), the effect of CPA (10 µM) (c),
the effect of CPA and 10 pM CCK together (d),
washout (e), and the effect of ionomycin (10 µM) and EGTA (10 mM) (Iono/EGTA)
(f). B, time course of ratio in the basolateral
and apical regions of the cell, which is measured in the regions
indicated in A (a). Arrows indicate
the time points at which corresponding ratio images shown in
A (b-f) were recorded.
1, n = 4) and deplete
[Ca2+]ER (Fig. 5B). We
also studied the effects of another receptor antagonist flunarizine (10 µM) on agonist-evoked and basal Ca2+ release.
In our study this compound, which is membrane-permeant and has been
previously reported to block directly the Ca2+ channel of
the IP3 receptor (27, 28), inhibited the effect of ACh;
however CCK and CPA were still able to deplete
[Ca2+]ER in the presence of
flunarizine (n = 4, not shown).

View larger version (14K):
[in a new window]
Fig. 5.
Responses of cells dialyzed with
intracellular solution containing the IP3 receptor
antagonist heparin (500 µg/ml).
A, the response to ACh (1 µM) is inhibited,
but CCK (10 pM and 10 nM) still evokes a
response. B, CPA (10 µM) still reveals the
basal leak when heparin is present in the intracellular solution.
1, n = 4).
Inhibition of CPA responses by 8-amino-cyclic ADP-ribose was not seen
even when the IP3 receptor blocker flunarizine was present
as well (n = 4). In order to investigate further
whether the basal leak could occur through the ryanodine receptor we
studied the effect on the basal leak of ruthenium red, a blocker of the ryanodine receptor (20, 31). These experiments were performed on
permeabilized cells, allowing relatively fast and simple changes of the
solutions in contact with the ER. In 16 permeabilized cells CPA (10 µM) evoked a mean ratio decrease of 0.021 ± 0.004 min
1, but ruthenium red (10 µM) had no
effect on this basal leak (Fig. 6B). We also studied the
effect of nifedipine and verapamil (both 100 µM) on the
basal Ca2+ leak in permeabilized cells. It has been
reported that in sea urchin eggs these Ca2+ channel
blockers completely inhibit the release of stored Ca2+
evoked by NAADP (32), but we found that in the pancreatic acinar cell
they had no effect on the basal Ca2+ leak evoked by CPA
(n = 8 cells for both compounds, data not shown).

View larger version (14K):
[in a new window]
Fig. 6.
Effects of inhibitors of ryanodine receptors
on the response to CCK and on the basal leak. A, in a
patch-clamped cell dialyzed with 8-NH2 cyclic ADP-ribose
(20 µM) the store-depleting effect of physiological dose
of CCK (10 pM) is inhibited, but CPA (10 µM)
is still able to reveal the basal leak. B, in a streptolysin
O-permeabilized cell, the basal leak evoked by CPA is not affected by
the ryanodine receptor blocker ruthenium red (RR, 10 µM). Subsequently,
[Ca2+]ER is depleted by a mixture
of ionomycin (10 µM) and EGTA (10 mM)
(Iono).

View larger version (14K):
[in a new window]
Fig. 7.
Time courses of depletion of
[Ca2+]ER by
puromycin. A, puromycin (100 and 500 µM)
depletes [Ca2+]ER in a dialyzed
cell. B, 500 µM puromycin evokes a decrease in
[Ca2+]ER in a streptolysin
O-permeabilized cell.

View larger version (17K):
[in a new window]
Fig. 8.
The depletion of
[Ca2+]ER by puromycin (500 µM) in permeabilized cells is not affected by the
IP3 receptor antagonist heparin (500 µg/ml)
(A) or the ryanodine receptor antagonist ruthenium red (10 µM) (B). C, in a permeabilized cell
in which inhibition of the SERCA pump by CPA (10 µM)
activates the basal Ca2+ leak, puromycin (500 µM) accelerates the depletion of
[Ca2+]ER. Subsequent application
of a mixture of ionomycin (10 µM) and EGTA (10 mM) (Iono/EGTA) further depletes the
Ca2+ store.
![]()
DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
| |
FOOTNOTES |
|---|
* This work was supported by a Medical Research Council program grant.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
These authors made similar contributions to the work.
§ To whom correspondence may be addressed: The Physiological Laboratory, Crown St., University of Liverpool, Liverpool L69 3BX, UK. Tel.: 44-151-794-5351; Fax: 44-151-794-5327; E-mail: rlomax@liv.ac.uk (to R. L.) and a.tepikin@liv.ac.uk (to A. T.).
¶ Postdoctoral fellow funded by the Consejería de Educación, Ciencia y Tecnología de la Junta de Extremadura.
Published, JBC Papers in Press, May 6, 2002, DOI 10.1074/jbc.M201845200
2 J. F. Rehfeld, personal communication.
| |
ABBREVIATIONS |
|---|
The abbreviations used are: ER, endoplasmic reticulum; [Ca2+]ER, intraluminal Ca2+; [Ca2+]C, cytosolic Ca2+; BAPTA, 1,2-bis-(2-aminophenoxy)ethane-N,N,N,N-tetraacetate; CCK, cholecystokinin; ACh, acetylcholine; IP3, inositol 1,4,5-trisphosphate; NAADP, nicotinic acid adenine dinucleotide phosphate; Iono, ionomycin; CPA, cyclopiazonic acid; SERCA, sarco/endoplasmic reticulum Ca2+-ATPase.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Berridge, M. J. (1993) Nature 361, 315-325[CrossRef][Medline] [Order article via Infotrieve] |
| 2. | Berridge, M. J. (2001) in Novartis Foundation Symposium (Bock, G. , and Goode, J., eds), Vol. 239 , pp. 52-64, John Wiley and Sons, Sussex, UK |
| 3. | Thomas, A. P., St., Bird, G., Hajnóczky, G., Robb-Gaspers, L. D., and Putney, J. W. (1996) FASEB J. 10, 1505-1517[Abstract] |
| 4. |
Pozzan, T.,
Rizzuto, R.,
Volpe, P.,
and Meldolesi, J.
(1994)
Physiol. Rev.
74,
595-636 |
| 5. | Cancela, J. M., Gerasimenko, O. V., Gerasimenko, J. V., Tepikin, A. V., and Petersen, O. H. (2000) EMBO J. 19, 2549-2557[CrossRef][Medline] [Order article via Infotrieve] |
| 6. |
Petersen, O. H.
(1992)
J. Physiol.
448,
1-51 |
| 7. | Hofer, A. M., Curci, S., Machen, T. E., and Schulz, I. (1996) FASEB J. 10, 302-308[Abstract] |
| 8. | Mogami, H., Tepikin, A. V., and Petersen, O. H. (1998) EMBO J. 17, 435-442[CrossRef][Medline] [Order article via Infotrieve] |
| 9. | Beecroft, M. D., and Taylor, C. W. (1998) Biochem. J. 334, 431-435[Medline] [Order article via Infotrieve] |
| 10. | Missiaen, L., de Smedt, H., Raeymaekers, L., Droogmans, G., van den Bosch, L., and Casteels, R. (1996) Biochem. J. 317, 849-853[Medline] [Order article via Infotrieve] |
| 11. | Pessah, I. N., Molinski, T. F., Mely, T. D., Wong, P., Buck, E. D., Allen, P. D., Mohr, F. C., and Mack, M. M. (1997) Am. J. Physiol. 272, C601-C614[Medline] [Order article via Infotrieve] |
| 12. | Overend, C. L., O'Neill, S. C., and Eisner, D. A. (1998) J. Physiol. 507, 750-769 |
| 13. | Smith, P. M., and Gallacher, D. V. (1994) Biochem. J. 299, 37-40[Medline] [Order article via Infotrieve] |
| 14. | Favre, C. J., Lew, D. P., and Krause, K.-H. (1994) Biochem. J. 302, 155-162[Medline] [Order article via Infotrieve] |
| 15. |
Simon, S. M.,
Blobel, G.,
and Zimmerberg, J.
(1989)
Proc. Natl. Acad. Sci. U. S. A.
86,
6176-6180 |
| 16. | Simon, S. M., and Blobel, G. (1991) Cell 65, 371-380[CrossRef][Medline] [Order article via Infotrieve] |
| 17. |
Heritage, D.,
and Wonderlin, W. F.
(2001)
J. Biol. Chem.
276,
22655-22662 |
| 18. | Pestka, S. (1974) Methods Enzymol. 30, 261-282[Medline] [Order article via Infotrieve] |
| 19. | Skogerson, L., and Moldave, K. (1968) Arch. Biochem. Biophys. 125, 497-505[CrossRef][Medline] [Order article via Infotrieve] |
| 20. | Bezprozvanny, I., Watras, J., and Ehrlich, B. E. (1991) Nature 351, 751-754[CrossRef][Medline] [Order article via Infotrieve] |
| 21. | Hammill, O. P., Marty, A., Neher, E., Sakmann, B., and Sigworth, F. J. (1981) Pflügers Arch. 391, 85-100[CrossRef][Medline] [Order article via Infotrieve] |
| 22. |
van de Put, F. H. M. M.,
and Elliott, A. C.
(1996)
J. Biol. Chem.
271,
4999-5006 |
| 23. |
Bolender, R. P.
(1974)
J. Cell Biol.
61,
269-287 |
| 24. | Park, M. K., Petersen, O. H., and Tepikin, A. V. (2000) EMBO J. 19, 5729-5739[CrossRef][Medline] [Order article via Infotrieve] |
| 25. |
Grynciewicz, G.,
Poenie, M.,
and Tsien, R. Y.
(1985)
J. Biol. Chem.
260,
3440-3450 |
| 26. | Ballinger, A., McLoughlin, L., Medbak, S., and Clark, M. (1995) Clin. Sci. 89, 375-381[Medline] [Order article via Infotrieve] |
| 27. | Seiler, S. M., Arnold, A. J., and Stanton, H. C. (1987) Biochem. Pharmacol. 36, 3331-3337[CrossRef][Medline] [Order article via Infotrieve] |
| 28. | Palade, P., Dettbarn, C., Alderson, B., and Volpe, P. (1989) Mol. Pharmacol. 36, 673-680[Abstract] |
| 29. | Walseth, T. F., and Lee, H. C. (1993) Biochim. Biophys. Acta 1178, 235-242[Medline] [Order article via Infotrieve] |
| 30. | Cancela, J. M., and Petersen, O. H. (1998) Pflügers Arch. 435, 746-748[CrossRef][Medline] [Order article via Infotrieve] |
| 31. |
Palade, P.
(1987)
J. Biol. Chem.
262,
6135-6141 |
| 32. |
Genazzani, A. A.,
Empson, R. M.,
and Galione, A.
(1996)
J. Biol. Chem.
271,
11599-11602 |
| 33. | Stevens, F. J., and Argon, Y (1999) Semin. Cell Dev. Biol. 10, 443-454[CrossRef][Medline] [Order article via Infotrieve] |
| 34. | Wetmore, D. R., and Hardman, K. D. (1996) Biochemistry 35, 6549-6558[CrossRef][Medline] [Order article via Infotrieve] |
| 35. |
Prostko, C. R.,
Dholakia, J. N.,
Bromstrom, M. A.,
and Bromstrom, C. O.
(1995)
J. Biol. Chem.
270,
6211-6215 |
| 36. |
Bromstrom, C. O.,
Prostko, C. R.,
Kaufmann, R. J.,
and Bromstrom, M. A.
(1996)
J. Biol. Chem.
271,
24995-25002 |
| 37. | Jeffery, J., Kendall, J. M., and Campbell, A. K. (2000) Biochem. Biophys. Res. Commun. 268, 711-715[CrossRef][Medline] [Order article via Infotrieve] |
| 38. | Pinton, P., Ferrari, D., Rapizzi, E., di Virgilio, F. D., Pozzan, T., and Rizzuto, R. (2001) EMBO J. 20, 2690-2701[CrossRef][Medline] [Order article via Infotrieve] |
| 39. | Thorn, P., Lawrie, A. M., Smith, P. M., Gallacher, D. V., and Petersen, O. H. (1993) Cell 74, 661-668[CrossRef][Medline] [Order article via Infotrieve] |
| 40. |
Ghosh, T. K.,
Eis, P. S.,
Mullaney, J. M.,
Ebert, C. L.,
and Gill, D. L.
(1988)
J. Biol. Chem.
263,
11075-11079 |
| 41. |
Matozaki, T.,
Göke, B.,
Tsunoda, Y.,
Rodriguez, M.,
Martinez, J.,
and Williams, J. A.
(1990)
J. Biol. Chem.
265,
6247-6254 |
| 42. |
Tortorici, G.,
Zhang, B.-X., Xu, X.,
and Muallem, S.
(1994)
J. Biol. Chem.
269,
29621-29628 |
| 43. | Yule, D. I., Stuenkel, E., and Williams, J. A. (1996) Am. J. Physiol. 271, C1285-C1294[Medline] [Order article via Infotrieve] |
| 44. | Crowley, K. S., Liao, S., Worrell, V. E., Reinhart, G. D., and Johnson, A. E. (1994) Cell 78, 461-471[CrossRef][Medline] [Order article via Infotrieve] |
| 45. | Hamman, B. D., Hendershot, L. M., and Johnson, A. E. (1998) Cell 92, 747-758[CrossRef][Medline] [Order article via Infotrieve] |
| 46. |
Potter, M. D.,
and Nicchitta, C. V.
(2002)
J. Biol. Chem.
277,
23314-23320 |
This article has been cited by other articles:
![]() |
R. Jimenez-Moreno, Z.-M. Wang, R. C. Gerring, and O. Delbono Sarcoplasmic Reticulum Ca2+ Release Declines in Muscle Fibers from Aging Mice Biophys. J., April 15, 2008; 94(8): 3178 - 3188. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. I. E. Bruce and A. C. Elliott Oxidant-impaired intracellular Ca2+ signaling in pancreatic acinar cells: role of the plasma membrane Ca2+-ATPase Am J Physiol Cell Physiol, September 1, 2007; 293(3): C938 - C950. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Jousset, M. Frieden, and N. Demaurex STIM1 Knockdown Reveals That Store-operated Ca2+ Channels Located Close to Sarco/Endoplasmic Ca2+ ATPases (SERCA) Pumps Silently Refill the Endoplasmic Reticulum J. Biol. Chem., April 13, 2007; 282(15): 11456 - 11464. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. M. Choi, S. H. Kim, S. Chung, D. Y. Uhm, and M. K. Park Regional Interaction of Endoplasmic Reticulum Ca2+ Signals between Soma and Dendrites through Rapid Luminal Ca2+ Diffusion. J. Neurosci., November 22, 2006; 26(47): 12127 - 12136. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Wang, M. T. H. Abreu, K. Siminovitch, G. P. Downey, and C. A. McCulloch Phosphorylation of SHP-2 Regulates Interactions between the Endoplasmic Reticulum and Focal Adhesions to Restrict Interleukin-1-induced Ca2+ Signaling J. Biol. Chem., October 13, 2006; 281(41): 31093 - 31105. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Lizak, I. Czegle, M. Csala, A. Benedetti, J. Mandl, and G. Banhegyi Translocon pores in the endoplasmic reticulum are permeable to small anions Am J Physiol Cell Physiol, September 1, 2006; 291(3): 511 - 517. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Vanden Abeele, G. Bidaux, D. Gordienko, B. Beck, Y. V. Panchin, A. V. Baranova, D. V. Ivanov, R. Skryma, and N. Prevarskaya Functional implications of calcium permeability of the channel formed by pannexin 1 J. Cell Biol., August 14, 2006; 174(4): 535 - 546. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Flourakis, F. Van Coppenolle, V. Lehen'kyi, B. Beck, R. Skryma, and N. Prevarskaya Passive calcium leak via translocon is a first step for iPLA2-pathway regulated store operated channels activation FASEB J, June 1, 2006; 20(8): 1215 - 1217. [Abstract] [Full Text] [PDF] |